retatrutide treatment duration clinical trials of subcutaneous tirzepatide, retatrutide, and Phase III retatrutide study demonstrates

A mild inflammatory infiltrate composed of lymphocytes and occasional eosinophils is also seen

Heart rate increases of 2-4 beats per minute have been observed across all three compounds, consistent with the broader GLP-1 drug class

GLP-1 is covered in some states for both diabetes and obesity treatment, while there may be restrictions in other states

"We envision these capabilities empowering consumers to proactively address health concerns such as vitamin deficiencies, un-optimized hormonal levels and genetic risk factors, while also identifying early indicators of more serious conditions like cancer and cardiovascular disease," he said